Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- 1 in 3 Women Don’t Know Menopause and Bone Loss Are Connected, New Osteoboost Data Reveals
- 5/28/2026 12:00:00 PM
- Disney and Philips Bring Beloved Storytelling and Innovative Technology to Support Kids Undergoing MRI Exams
- 5/28/2026 11:43:22 AM
- The Walt Disney Company and Philips today announced that beloved Disney animated characters and stories are being incorporated directly into Philips Ambient Experience for MRI at medical facilities in 87 countries worldwide.
- Scars of Life: Study Shows Impact of Atopic Dermatitis on Educational and Career Choices
- 5/28/2026 11:32:40 AM
- Atopic dermatitis (AD), the most common form of eczema, impacts patients’ life trajectories beyond the physical scars. A novel study shows that adults with AD, particularly those with childhood onset, report significantly greater limitations in their educational and professional choices, with up to 38% of childhood-onset patients reporting career restrictions and more than …
- Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
- 5/28/2026 9:37:11 AM
- The US Food and Drug Administration (FDA) has granted priority review to the new drug application (NDA) for venglustat, a novel, investigational oral glucosylceramide synthase inhibitor (GCSi), for the treatment of type 3 Gaucher disease (GD3), a rare lysosomal storage disorder.
- MindMaze Therapeutics Chooses Connect Labs by Wexford at Charlotte’s The Pearl Innovation District for U.S. Headquarters to Advance Neurological Care
- 5/28/2026 9:00:00 AM
- MindMaze Therapeutics, a pioneer in precision neurotherapeutics, has announced a U.S headquarters at The Pearl, Charlotte’s Innovation District, a partnership between Atrium Health and Wexford Science & Technology, LLC.
- Wiley Bolsters Research Integrity Efforts with Imagetwin’s Enhanced Image Screening
- 5/26/2026 10:00:47 AM
- Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced that it has integrated Imagetwin’s leading AI-powered image integrity software into Research Exchange, its award-winning research publishing platform.
- Shofu, Tosoh, Mitsui Chemicals, and Orbray Launch Joint Project to Recycle Zirconia Dental Waste
- 5/22/2026 12:20:28 PM
- Shofu Inc. (headquartered in Kyoto, Kyoto Prefecture; Tetsuo Takami, Representative Director, President & COO); Tosoh Corporation (headquartered in Chuo-ku, Tokyo; Mamoru Kuwada, president and representative director); Mitsui Chemicals, Inc.
- EBOLA OUTBREAK: "Unless a collective effort is made, this crisis is going to get worse"
- 5/22/2026 12:08:10 PM
- Save the Children is rushing to contain an Ebola outbreak in the Democratic Republic of Congo, where decimated healthcare systems are ill equipped to stop its spread.
- AMA on Ways and Means unanimously endorsing budget neutrality reform
- 5/22/2026 10:59:04 AM
- Statement attributable to: Bobby Mukkamala, MD President, American Medical Association “Physicians are grateful that the House Ways and Means Committee took a major step in curing a flawed budget policy that results in physicians facing Medicare cuts every year.
- Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
- 5/21/2026 12:11:34 PM
- AstraZeneca’s Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to lower blood pressure in adults who are not adequately controlled.
- AMA statement on HHS removing vice chairs of USPSTF
- 5/21/2026 11:52:08 AM
- Statement attributable to: Bobby Mukkamala, MD President, American Medical Association “The AMA is extremely concerned by today’s HHS decision to remove the vice-chairs of the U.S.
- WHO and Gilead Sciences renew partnership to accelerate visceral leishmaniasis elimination
- 5/21/2026 11:44:45 AM
- The World Health Organization (WHO) and Gilead Sciences have renewed their partnership through a new five-year agreement (2026–2030) to support the elimination of visceral leishmaniasis (VL), a life-threatening neglected tropical disease.
- Novel Mouse Model Mirrors Human Pathology of Geleophysic Dysplasia, Facilitating Research
- 5/21/2026 11:08:02 AM
- Researchers have developed a novel mouse model that replicates severe geleophysic dysplasia, including short stature, heart valve alterations, and early lethality—characteristics of this rare disease.
- New MRC investment supports clinical research careers in the UK
- 5/20/2026 9:43:47 AM
- The investment will establish 10 Regional Accounts for Clinical Researchers (RACR), bringing together more than 50 research organisations and over 60 NHS organisations across England, Scotland, Wales and Northern Ireland.
- “Brain Signatures Whisper Warnings:” Researchers Identify Age 9 as Critical Turning Point for Anxiety and Depression
- 5/19/2026 12:22:32 PM
- A longitudinal study tracking children over a period of seven years identified distinct brain-wave patterns emerging from age 9 can forecast a child’s vulnerability to anxiety or depression by age 13.
- UNICEF scaling up efforts to protect and support children and families following Ebola outbreaks in the Democratic Republic of the Congo and Uganda
- 5/19/2026 12:05:35 PM
- “UNICEF is deeply concerned by confirmed Ebola outbreaks in the Democratic Republic of the Congo (DRC) and Uganda, and the growing risk to children and vulnerable communities across the region – a situation the World Health Organization has now declared a Public Health Emergency of International Concern.
- ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
- 5/19/2026 11:15:38 AM
- • Data from the head-to-head study show efdoralprin alfa normalized and maintained functional AAT levels in people living with alpha-1 antitrypsin deficiency • Efdoralprin alfa is a recombinant protein distinct from plasma-derived therapy, which has been the standard-of-care for nearly 40 years Data from the global ElevAATe phase 2 study (clinical study …
- ConV2X 2026 Releases Preliminary Agenda for Cambridge Summit on Decentralized Health Systems
- 5/18/2026 8:00:00 AM
- ConV2X has announced the preliminary agenda for its 2026 summit, outlining a three-day program focused on the structural transformation of healthcare systems through AI, decentralized infrastructure, data sovereignty, clinical intelligence, and regulatory modernization.
- Introducing Chromie Health: A Startup Developing AI Agents to Automate Hospital Staffing
- 5/14/2026 12:02:10 PM
- Chromie Health, one of the world’s fastest-growing AI-powered scheduling and management platform for hospital operations, today announced a $2 million pre-seed round led by AIX Ventures along with the launch of Chromie Dispatch, the company’s flagship AI agent that instantly fills internal shift gaps via simple SMS.
- Global study of clinicians by Elsevier finds nurses being left out of clinical AI adoption
- 5/13/2026 4:09:16 PM
- Elsevier’s Clinician of the Future 2026 report reveals emerging gaps in AI adoption, especially for clinician-specific solutions. In particular, nurses report feeling underrepresented both in AI use and in organizational decision-making around AI.